Bengaluru-based NGO's hemoglobinopathy prevention programme has averted 201 affected births across five States
Inherited blood disorders such as thalassemia and sickle cell disease (also known as hemoglobinopathies) inflict lifelong suffering, including repeated transfusions, painful complications, disability, and early death.
1.9 lakh screened
In the last four years, the NGO, Sankalp India Foundation, screened over 1.9 lakh women in 81 districts across Maharashtra, Madhya Pradesh, Gujarat, Karnataka, and Andhra Pradesh. It was possible to prevent 201 births with severe hemoglobinopathies. These included 91 sickle cell disease, 76 thalassemia major, 27 sickle-beta thalassemia, and seven other hemoglobinopathies.
Proactive measures, including genetic counseling and prenatal screening, enabled families to make informed decisions about continuing or terminating pregnancies based on fetal test results.
28 from Karnataka
The 201 births include 28 from Karnataka, 123 from Maharashtra, 12 from Andhra Pradesh, 13 from Gujarat, and 25 from Madhya Pradesh. 'The number of affected births that have been prevented corresponds to the carrier (of mutated genes that cause the hemoglobinopathies but do not have the disease themselves) rates in these States,' Rajat Kumar Agarwal, president of Sankalp India Foundation, told The Hindu on Saturday.
Pointing out that the programme is a scalable model of national importance, Mr. Agarwal said, 'As India commits to eliminating sickle cell disease by 2047, this programme offers a working blueprint of how to make that vision a reality.'
This impact was only possible because of strong partnerships with National Health Missions in the five States, district health authorities, local health workers, donor institutions, and other stakeholders. It reflects a model of public-private collaboration rooted in equity, trust, and local leadership, he said.
As many as 87 centre coordinators and six regional coordinators trained and embedded in the Obstetrics/ Gynaecology departments in district hospitals were at the frontline. 'They counselled parents-to-be, mobilised timely testing, supported prenatal diagnosis, and offered continuity of care with unwavering compassion and clarity,' he added.
Hardest decision
Couples, who were counselled and tested, said they had no idea they were both carriers. 'Following the genetic testing, terminating the pregnancy was the hardest decision of our lives. But, we were not prepared to see our child suffer lifelong,' said Jayshree and M. Ravi, who were counselled and tested through the NGO at Tumkuru district hospital.
'The programme gave us knowledge and choices to ensure a healthy future for our child,' said Seema and Mahesh from Alirajpur in Madhya Pradesh.
Sundar Periyavan, lab director of Sankalp Labs and former Head of Haematology and Transfusion Medicine at NIMHANS, said accurate and timely diagnostics are the lifeline of this programme.
Quick and precise
'Every hour counts, and our labs ensure fast, accurate, and actionable results through high-performance liquid chromatography (HPLC). The families receive clear answers when it matters most,' the doctor said.
The clinical framework and quality systems of this programme were conceptualised by Lawrence Faulkner, medical director of Sankalp and founder of Cure2Children, Italy, an international haematologist.
'Sankalp's antenatal screening model, grounded in precision diagnostics and community engagement, has transformed the way we approach hemoglobinopathy prevention,' said Dr. Faulkner.
(Names of the couples have been changed).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
44 minutes ago
- Time of India
3 times makhana may be bad for you: Nutritionist cautions against the ‘guilt-free' snack
Fox nuts or makhana may seem like a miracle snack, but moderation is key. Nutritionist Nandini Agarwal highlights three scenarios where overindulgence can backfire—chronic constipation, excessive calorie intake while dieting, and complications for those with kidney ailments. Though rich in protein and antioxidants, makhana's dark side proves even healthy snacks need a balanced approach. Tired of too many ads? Remove Ads The Constipation Conundrum The Calorie Trap in a Healthy Cloak Tired of too many ads? Remove Ads Kidneys and Potassium: A Caution for CKD Patients A Grain of Salt with Every Superfood In the age of kale chips and quinoa bowls, makhana —those light, airy lotus seeds—have become India's answer to guilt-free snacking . Touted for their health benefits and endorsed by fitness influencers and wellness gurus alike, these fox nuts have carved a niche in the ' superfood ' club. But, as it turns out, even the healthiest of snacks come with Nandini Agarwal recently took to Instagram to drop a reel that's stirring up the wellness world. While makhana is often hailed as a nutritional powerhouse , Agarwal's reel highlighted that it's not always the best choice for everyone. Her three-point warning isn't a dismissal of makhana's benefits—it's a gentle but timely reminder that 'healthy' isn't always you've been leaning on makhana as your go-to midday snack and have also been noticing trouble in the gut, it might be time to reassess. Agarwal points out that makhana is relatively low in fiber. That means for individuals already dealing with constipation, consuming makhana regularly can worsen the issue. It's ironic, considering how makhana is often grouped with other fiber-rich snacks—but in reality, it's the texture, not the fiber, that fools many into thinking it's good for her reel, Agarwal advises, 'Under constipation, these nuts do not have too much fiber and can cause more constipation.' So, while makhana may seem light and digestible, it doesn't do much for keeping your digestive tract moving—something worth noting before your next weight loss regimes in full swing on social media, makhana has become a darling of the diet world. Roasted, spiced, and presented as a 'binge-worthy' alternative to chips, it feels harmless. But as Agarwal notes, 'If you're trying to lose weight then 100 grams of makhana is still okay—but if you're overdoing it, it is definitely not okay.' The reason? Makhana, though low in fat, contains considerable carbohydrates. Eat too much, and those calories stack up faster than you'd other words, just because it's not deep-fried doesn't mean it's diet-proof. Mindful munching is key—even with the healthiest of the most critical warning Agarwal gives is for those with kidney issues or Chronic Kidney Disease (CKD). Makhana is naturally high in potassium—a mineral often restricted in low-potassium renal diets. 'If you have kidney issues or CKD and you are on a low potassium diet, then you should definitely avoid eating makhanas totally,' she third reason is a vital reminder that what's good for one body might not suit another. In such cases, consulting a healthcare professional before adopting trendy dietary habits becomes makhana remains a versatile and nutrient-rich snack—high in protein, antioxidants, and minerals—it's important to remember that even superfoods have their shadows. Nandini Agarwal's Instagram reel doesn't vilify makhana, but rather humanizes it in a world where nutrition is too often reduced to black-and-white labels.
The Hindu
2 hours ago
- The Hindu
Naruvi Hospitals, The Hindu to jointly host webinar on management of GERD
Naruvi Hospitals, Vellore, in association with The Hindu, is presenting a webinar on 'GERD-Free Living: From Burn to Balance', at 11.30 a.m. on July 20. This is a part of the 'Healthy India, Happy India' webinar series — a 15-part initiative on the theme of 'Prevent Illness, Promote Wellness'. Gastroesophageal Reflux Disease (GERD) is an increasingly common lifestyle disorder that affects individuals across all age groups. This webinar aims to raise awareness of GERD by addressing its early symptoms, methods of accurate diagnosis, available treatment options, and sustainable lifestyle changes to effectively manage and prevent the condition. This 15th session in the series brings together a panel of doctors who will share their insights on GERD: E. Rabindranath, consultant gastroenterologist, Naruvi Hospitals, Vellore will speak on 'Diagnosis, Lifestyle Changes and Managing GERD', while Jacob Raja A. S, consultant gastroenterologist, consultant in infectious diseases, Naruvi Hospitals, Vellore will speak on 'Introduction and Symptomatology of GERD'. A. C. Arun, clinical lead, gastroenterology, Lily Mission Hospital, Madurai, will elaborate on the 'Treatment of Refractory GERD'. Soma Basu, Senior Deputy Editor, The Hindu will moderate the session. E-certificates will be issued to all those who register for the webinar. To register, visit or scan the QR code.
Time of India
5 hours ago
- Time of India
Healthcare firm Heartflow's IPO filing discloses wider loss
Bengaluru: Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S. initial public offering on Thursday, at a time when it looks to tap into renewed investor appetite for new listings. The U.S. IPO market is recovering from months of sluggish activity triggered by trade policy uncertainty under President Donald Trump. Both Omada, a virtual healthcare provider, and cancer diagnostic firm Caris Life Sciences saw strong investor reception when they debuted last month. Mountain View, California-based Heartflow posted a loss of $32.3 million for the three months ended March 31, compared with a loss of $20.9 million a year earlier, the IPO filing showed. Its revenue was $37.2 million for the quarter, compared with $26.8 million a year ago. Proceeds from the IPO will be used to pay down debt, fund sales and marketing, research and product development activities and other general corporate purposes, the company said. Heartflow develops an artificial intelligence-powered heart imaging tool, which creates personalized 3D models of the organ, helping doctors detect blockages, minimize unnecessary testing and optimize treatment. The company will list on the Nasdaq under the symbol "HTFL".
